Know the Facts about Coronavirus Disease 2019 (COVID-19)

Condition | Neurology


  • IRB Number: NIH 683
  • Contact Name: Cheryl Weber, RN, MS, CCRC
  • Status: Open
  • Phone: 585-922-4111
  • Lead Researcher: W. Scott Burgin, MD


WARCEF - Warfarn vs. Aspirin in Reduced Cardiac Ejection Fraction. Includes Change in Eligibility Criteria (Eligibility Ejection Fraction Has Been Increased From less than 30 to less than 35%) To compare the efficacy and safety of Warfarin (INR 2.0-3.0) with aspirin (325 mg per day) for preventing all-cause mortality and disability in patients with cardiac EF less than 35%.